These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 19803)
21. MSH and MIF-I in animal models of tardive dyskinesia. Davis KL; Kastin AJ; Beilstein BA; Vento AL Pharmacol Biochem Behav; 1980 Jul; 13(1):37-40. PubMed ID: 6105677 [TBL] [Abstract][Full Text] [Related]
22. Parameters of alteration of pentobarbital response by hypothalamic polypeptides. Prange AJ; Breese GR; Jahnke GD; Cooper BR; Cott JM; Wilson IC; Lipton MA; Plotnikoff NP Neuropsychobiology; 1975; 1(2):121-31. PubMed ID: 817220 [TBL] [Abstract][Full Text] [Related]
23. Alpha-melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants. McFarlane D; Beech J; Cribb A Domest Anim Endocrinol; 2006 May; 30(4):276-88. PubMed ID: 16115743 [TBL] [Abstract][Full Text] [Related]
24. Effects of the tripeptides TRH, MIF and MAF on the cerebral dopaminergic system. Klusha B; Georgiev V; Petkov V; Markovska V Acta Physiol Pharmacol Bulg; 1983; 9(2):14-9. PubMed ID: 6140814 [TBL] [Abstract][Full Text] [Related]
25. Melanocyte-stimulating hormone release-inhibiting factor (MIF): lack of dopaminergic and anticholinergic activity. Carolei A; Margotta V; Palladini G Neuroendocrinology; 1977; 23(3):129-32. PubMed ID: 19714 [TBL] [Abstract][Full Text] [Related]
26. Prolyl-leucyl-glycinamide, thyrotropin-releasing hormone and beta-endorphin-(10-16), like antidepressants, antagonize melatonin-induced behavioural changes in rats. Hatta K; Wolterink G; Van Ree JM Eur J Pharmacol; 1995 Sep; 284(3):327-30. PubMed ID: 8666016 [TBL] [Abstract][Full Text] [Related]
27. [Montirelin hydrate (NS-3), a TRH analog, improved the disturbance of consciousness caused by head concussion and pentobarbital in mice]. Mushiroi T; Shibahara R; Tamura M; Shimizu T; Itoh Y; Ukai Y; Yoshikuni Y; Kimura K Nihon Yakurigaku Zasshi; 1996 May; 107(5):237-45. PubMed ID: 8690305 [TBL] [Abstract][Full Text] [Related]
31. Peptides and thermoregulation. Yehuda S; Kastin AJ Neurosci Biobehav Rev; 1980; 4(4):459-71. PubMed ID: 6110198 [TBL] [Abstract][Full Text] [Related]
32. Thyrotropin-releasing hormone (TRH) and its analog (DN-1417): interaction with pentobarbital in choline uptake and acetylcholine synthesis of rat brain slices. Narumi S; Nagai Y; Miyamoto M; Nagawa Y Life Sci; 1983 Apr; 32(14):1637-45. PubMed ID: 6403792 [TBL] [Abstract][Full Text] [Related]
33. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone. Rotllant J; Balm PH; Ruane NM; Pérez-Sánchez J; Wendelaar-Bonga SE; Tort L Gen Comp Endocrinol; 2000 Aug; 119(2):152-63. PubMed ID: 10936035 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and central nervous system actions of thyrotropin-releasing hormone analogues containing a dihydroorotic acid moiety. Suzuki M; Sugano H; Matsumoto K; Yamamura M; Ishida R J Med Chem; 1990 Aug; 33(8):2130-7. PubMed ID: 2115588 [TBL] [Abstract][Full Text] [Related]
35. Neuropeptide Y inhibits spontaneous alpha-melanocyte-stimulating hormone (alpha-MSH) release via a Y(5) receptor and suppresses thyrotropin-releasing hormone-induced alpha-MSH secretion via a Y(1) receptor in frog melanotrope cells. Galas L; Tonon MC; Beaujean D; Fredriksson R; Larhammar D; Lihrmann I; Jegou S; Fournier A; Chartrel N; Vaudry H Endocrinology; 2002 May; 143(5):1686-94. PubMed ID: 11956150 [TBL] [Abstract][Full Text] [Related]
36. Seasonal changes in plasma adrenocorticotropic hormone and α-melanocyte-stimulating hormone in response to thyrotropin-releasing hormone in normal, aged horses. Funk RA; Stewart AJ; Wooldridge AA; Kwessi E; Kemppainen RJ; Behrend EN; Zhong Q; Johnson AK J Vet Intern Med; 2011; 25(3):579-85. PubMed ID: 21457320 [TBL] [Abstract][Full Text] [Related]
37. Effect of thyrotropin-releasing hormone on pentobarbitone-induced sleep in rats: continuous treatment with a sustained release injectable formulation. Hashimoto T; Wada T; Fukuda N; Nagaoka A J Pharm Pharmacol; 1993 Feb; 45(2):94-7. PubMed ID: 8095539 [TBL] [Abstract][Full Text] [Related]
38. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog, (I): Effects on the central nervous system by oral administration. Yamamura M; Kinoshita K; Nakagawa H; Tanaka T; Maeda K; Ishida R Jpn J Pharmacol; 1990 Aug; 53(4):451-61. PubMed ID: 2120494 [TBL] [Abstract][Full Text] [Related]
39. Interaction of alpha-MSH and MIF-I with amphetamine on open-field behavior of rats. Sandman CA; Kastin AJ Pharmacol Biochem Behav; 1978 Dec; 9(6):759-62. PubMed ID: 34173 [No Abstract] [Full Text] [Related]
40. Effects of thyrotropine releasing hormone (TRH) on pentobarbital-induced decrease in cholinergic neuronal activity. Schmidt DE Commun Psychopharmacol; 1977; 1(5):469-73. PubMed ID: 414879 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]